Not registered yet? Get a free account.

Sign Up
search icon cancel icon

IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED

Active
Updated: 06 Jun 2025

Immunoadoptive Cell Therapy Private Limited, is an unlisted private company incorporated on 08 October, 2018. It is classified as a private limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 49.00 lac and the total paid-up capital is INR 2.01 lac.

Immunoadoptive Cell Therapy's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's book networth has increased by 157.06%.

Read more

Subscription Plans
Industry and products
Business Services
  • Scientific research and development, HUMN,ANML & OTHR BLD FR MDCNL USE; MDFD IMUNLGCL PRDTS W/N BY BITECH PROCES;VCCNS,TXNS,CLTRS OF MCRORGNSM & SMLR PRDCT
Company size
Auth Capital
₹ 49.0 L
Paidup Capital
₹ 2.0 L
Revenue
₹ 10-25 cr
Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue
1454.31%
₹ GET PRO
EBITDA
-
₹ GET PRO
Net Profit
-
₹ GET PRO
Networth
157.06%
₹ GET PRO
Borrowings
-
₹ GET PRO
Assets
153.42%
₹ GET PRO
Gross Margin
625.67
GET PRO %
Operating Margin
2409.07
GET PRO %
Net Profit Margin
1313.82
GET PRO %
Return on Equity
10.76
GET PRO %
ROCE
13.2
GET PRO %
Debt to Equity
-
GET PRO
Sales
Mar 2024
Net worth
Mar 2024

Locations

indian flag India (1)
State Type Address

location icon Locations on Map

Map placeholder

People

Designation Name DIN/PAN Tenure
Director Ravindranath Kancherla 00117940 4 years
Director Chava Satyanarayana 00211921 4 years
Director Shirish Arya 05356174 4 years
Director Rahul Purwar
Shareholder
08251942 7 years
Director Shalini Rahul Purwar
Shareholder
08251943 7 years
Director Atharva Ajay Karulkar 09381466 4 years

Financial Highlights

Financials upto March 2024 available in Tofler Pro
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%

Financials upto March 2024 available in Tofler Pro

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Charges on assets

As per information available, the company has no registered charges.

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
GLOBAL HOSPITAL (NORTH) LIMITED
Active
22.0 L 1 Delhi
GLOBAL CLINICAL RESEARCH SERVICES PRIVATE LIMITED
Active
2.2 Cr 1 Telangana
COGNITIVEBOTICS TECHNOLOGIES PRIVATE LIMITED
Active
1.6 Cr 1 Telangana
HYGIEIA GLOBAL HEALTH SERVICES PRIVATE LIMITED
Active
1.0 L 1 Telangana
GLOBAL UNIVERSITY FOUNDATION
Active
14.0 L 1 Telangana
RAVINDRANATH MEDICAL FOUNDATION
Active
29,000.0 1 Telangana
GLOBAL HOSPITALS HYDERABAD PRIVATE LIMITED
Active
1.0 L 1 Telangana
GLOBAL MEDLABS PRIVATE LIMITED
Active
1.0 L 1 Telangana
GLOBAL HOSPITALS PRIVATE LIMITED
Active
36.3 Cr 1 Telangana
ARUNACHALAM AUTOMOTIVES PRIVATE LIMITED
Active
1.0 L 1
LAURUS LABS LIMITED
Active
108.0 Cr 2
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
Active
0.0 1 Telangana
NOWPOS M-SOLUTIONS PRIVATE LIMITED
Amalgamated
15.7 Cr 1 Telangana
CHEMIASOFT PRIVATE LIMITED
Active
20.3 Cr 1 Telangana
LAURUS BIO PRIVATE LIMITED
Active
26.3 L 1
KRKA PHARMA PRIVATE LIMITED
Active
215.0 Cr 1
XYLEM INTEGRATED SOLUTIONS PRIVATE LIMITED
Active
1.7 Cr 1 Maharashtra
ADVY CHEMICAL PRIVATE LIMITED
Active
4.0 Cr 1

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Registered Details

CIN

U74999MH2018PTC315497

PAN

AAFCI0254E

Incorporation

2018, 6.8 years

Company Email

rahul.purwar@immunoact.com

Paid up Capital

₹ 2.0 L

Authorised Capital

₹ 49.0 L

AGM

May 2024

Type

Private
Non-government Company

FAQ - IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED

What is the incorporation date of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED?

plus icon

The incorporation date of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED is 08 October, 2018

What is the authorized share capital of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED?

plus icon

The authorized share capital of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED is INR ₹ 49.0 L.

What is the paid-up capital of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED?

plus icon

The paid-up capital of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED is INR ₹ 2.0 L.

What is the registered address of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED?

plus icon

The registered address of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED is CM-05, SINE Office, 3rd Floor CSRE Building, IIT Bombay, P owai NA MUMBAI Mumbai City Maharashtra - 400076

What is the CIN number of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED?

plus icon

The CIN number of IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED is U74999MH2018PTC315497.

Smart Suggestions

  • Telangana
  • Chandigarh
  • Karnataka
  • Jharkhand
  • Manipur
  • Meghalaya
  • Delhi
  • Pondicherry
  • Tamil Nadu
  • Assam
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More